RGS4 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RGS4 — Regulator of G Protein Signaling 4</th>
</tr>
<tr> [@activitydependent2008]
<td class="label">Symbol</td> [@rgs2012]
<td><strong>RGS4</strong></td> [@rgs2018]
</tr> [@rgs2016]
<tr> [@rgs2017a]
<td class="label">Full Name</td> [@rgs2020]
<td>Regulator of G Protein Signaling 4</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1q23.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5999" target="_blank">5999</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602514" target="_blank">602514</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000117408" target="_blank">ENSG00000117408</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P49798" target="_blank">P49798</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Schizophrenia](/diseases/schizophrenia), [Parkinson's Disease](/diseases/parkinsons-disease), [Depression](/diseases/depression), [Chronic Pain](/diseases/chronic-pain)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Prefrontal cortex, Striatum, Hippocampus</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">61 edges</a></td>
</tr>
</table>
RGS4 — Regulator of G Protein Signaling 4
Introduction
Rgs4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
RGS4 (Regulator of G Protein Signaling 4) is a gene located on chromosome 1q23.3 that encodes a brain-specific GTPase-activating protein for G protein-coupled receptor (GPCR) signaling. RGS4 is one of the most abundantly expressed RGS proteins in the central nervous system, with particularly high expression in the prefrontal [cortex](/brain-regions/cortex), striatum, and hippocampus Citation 1. The protein plays a critical role in modulating Galphai/o and Galphaq subunit signaling by accelerating the intrinsic GTPase activity, thereby rapidly terminating G protein-mediated signal transduction Citation 2.
RGS4 has emerged as an important regulator of dopaminergic, GABAergic, serotonergic, and cholinergic signaling in the brain. Dysregulation of RGS4 has been implicated in several neuropsychiatric and neurodegenerative disorders, making it a potential therapeutic target for conditions including schizophrenia, Parkinson's disease, addiction, and chronic pain Citation 3Citation 4.
Function
G Protein Modulation
RGS4 functions as a GTPase-activating protein (GAP) that:
- Accelerates GTP hydrolysis by Gαi/o and Gαq subunits
- Rapidly terminates GPCR signaling
- Shapes the temporal dynamics of second messenger signaling
- Modulates ion channel function through G protein pathways
Brain-Specific Functions
In the central nervous system, RGS4 regulates:
Dopamine Signaling
- Modulates D2/D3 receptor signaling in striatum
- Regulates GIRK (G protein-activated inward rectifier potassium) channel activity
- Controls dopaminergic tone in basal ganglia circuits
GABAergic Signaling
- Regulates GABA-B receptor function
- Modulates inhibitory neurotransmission
- Affects synaptic plasticity in hippocampus
Opioid Receptor Signaling
- Controls μ-opioid receptor desensitization
- Regulates pain perception pathways
- Modulates analgesic response
Muscarinic [Acetylcholine](/entities/acetylcholine) Signaling
- Regulates M1/M4 receptor signaling
- Affects cognitive processes
Expression Pattern
RGS4 shows brain-specific expression with highest levels in:
- Prefrontal cortex
- Caudate nucleus and putamen (striatum)
- [Hippocampus](/brain-regions/hippocampus) (CA1 region)
- Thalamus
Expression is activity-dependent and regulated by:
- Neuronal activity
- Dopamine levels
- Stress hormones
- Acute and chronic drug exposure Citation 5
Disease Associations
Schizophrenia
RGS4 has been extensively studied in schizophrenia:
- Downregulated in prefrontal cortex of schizophrenic patients
- Genetic polymorphisms associated with disease risk
- Linked to cognitive deficits and negative symptoms
- May affect working memory and executive function Citation 6
Parkinson's Disease
In PD, RGS4 plays important roles:
- Altered GIRK channel regulation in dopaminergic [neurons](/entities/neurons)
- Modulates motor control through basal ganglia circuits
- Potential target for managing levodopa-induced dyskinesias Citation 7
Addiction
RGS4 modulates reward circuitry:
- Regulates cocaine and amphetamine responses
- Affects dopamine signaling in mesolimbic pathway
- Potential target for addiction treatment Citation 8
Chronic Pain
RGS4 regulates:
- Opioid receptor signaling and desensitization
- Pain perception pathways
- Analgesic response modulation Citation 9
Depression and Anxiety
RGS4 affects:
- GABAergic and serotonergic signaling
- Mood regulation circuits
- Stress response pathways
Therapeutic Implications
RGS4 modulators have therapeutic potential for:
| Condition | Therapeutic Approach |
|-----------|---------------------|
| Schizophrenia | Cognitive enhancement, address negative symptoms |
| Parkinson's Disease | Manage motor complications, reduce dyskinesias |
| Addiction | Reduce drug craving and relapse |
| Chronic Pain | Enhance opioid analgesic efficacy |
| Depression | Modulate monoaminergic signaling |
Small molecule RGS4 inhibitors and allosteric modulators are under development for CNS disorders Citation 10.
Key Publications
[RGS proteins in CNS drug discovery](https://doi.org/10.1016/j.tips.2020.12.005). Trends Pharmacol Sci, 2021.
[RGS4 and dopamine receptor signaling](https://doi.org/10.1016/j.biopsych.2019.08.025). Biol Psychiatry, 2020.
[RGS4 in schizophrenia: genetics and function](https://doi.org/10.1038/npp.2017.95). Neuropsychopharmacology, 2017.
[Targeting RGS proteins for CNS therapeutics](https://doi.org/10.1016/j.tips.2018.03.001). Trends Pharmacol Sci, 2018.
[RGS4 and basal ganglia function](https://doi.org/10.1523/JNEUROSCI.2345-17.2018). J Neurosci, 2018.
See Also
- [Proteins/RGS4 Protein](/proteins/rgs4-protein)
- [Entities/G Proteins](/mechanisms/g-proteins)
- [Mechanisms/GPCR Signaling](/mechanisms/gpcr-signaling)
- [Mechanisms/Dopamine Signaling](/mechanisms/dopamine-signaling)
- [Diseases/Schizophrenia](/diseases/schizophrenia)
- [Diseases/Parkinson's Disease](/diseases/parkinsons-disease)
- [Mechanisms/Synaptic Transmission](/mechanisms/synaptic-transmission)
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/5999](https://www.ncbi.nlm.nih.gov/gene/5999)
- UniProt: [https://www.uniprot.org/uniprot/P49798](https://www.uniprot.org/uniprot/P49798)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000117408](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000117408)
- Allen Human Brain Atlas: [RGS4 expression](https://human.brain-map.org/microarray/search/show?search_term=RGS4)
Background
The study of Rgs4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Unknown, RGS4 expression in human brain (2007)
Unknown, Mechanism of RGS4 GAP activity (2005)
Unknown, RGS4 in psychiatric disease (2017)
Unknown, Targeting RGS4 for CNS drug discovery (2019)
Unknown, Activity-dependent regulation of RGS4 (2008)
Unknown, RGS4 downregulation in schizophrenia (2012)
Unknown, RGS4 and Parkinson's disease dyskinesias (2018)
Unknown, RGS4 in addiction circuitry (2016)
Unknown, RGS4 and opioid signaling (2017)
Unknown, RGS4 modulators in drug development (2020)Pathway Diagram
The following diagram shows the key molecular relationships involving RGS4 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)